Alzheimer's disease (AD) is characterized by Amyloid, Tau, and Neurofilament chain (NfL: a newer biomarker of neurodegeneration) pathology (ATN), which summarizes neural injury and accumulation of amyloid and tau plaques in the brain. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.